|
|
|
Insider
Information: |
Rowinsky Eric K |
Relationship: |
Director |
City: |
Branchburg |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
589,560 |
|
Indirect Shares
|
2,000 |
|
|
Direct
Value |
$6,599,033 |
|
|
Indirect Value
|
$7,360 |
|
|
Total
Shares |
591,560 |
|
|
Total
Value |
$6,606,393 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
5
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
5
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
-5.0
|
Percentage
Gain/Loss : |
-31.9%
|
-94.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
Director |
2024-02-15 |
20,629 |
2010-03-22 |
0 |
Premium* |
|
Navidea Biopharmaceuticals |
NAVB |
Director |
2018-02-20 |
341,446 |
2011-08-19 |
0 |
Premium* |
|
Stemline Therapeutics Inc |
STML |
Chief Medical Officer |
2015-04-27 |
143,688 |
2013-04-24 |
0 |
Premium* |
|
Fortress Biotech, Inc. |
FBIO |
Director |
2024-01-01 |
68,797 |
2014-02-20 |
0 |
Premium* |
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-29 |
15,000 |
2016-08-29 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2017-09-05 |
0 |
2017-09-05 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FBIO |
Fortress Biotech, Inc. |
Director |
|
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
450,000 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
880 |
15,024 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
550,000 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2019-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,155 |
16,179 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2020-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
650,000 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
890 |
17,069 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2021-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
750,000 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
775 |
17,844 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
820,000 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,370 |
19,214 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2023-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
920,000 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2023-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
960 |
20,174 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,666 |
68,797 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2017-06-30 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
291,446 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2018-02-20 |
4 |
A |
$0.00 |
$50 |
D/D |
50,000 |
341,446 |
0 |
- |
|
BIND |
DNIB Upwind Inc |
Director |
|
2016-08-29 |
4 |
OE |
$0.44 |
$6,600 |
D/D |
15,000 |
15,000 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Director |
|
2017-09-05 |
4 |
B |
$3.84 |
$7,680 |
I/I |
2,000 |
2,000 |
2.1 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2021-02-16 |
4 |
S |
$3.86 |
$7,720 |
D/D |
(2,000) |
744,000 |
0 |
% |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2023-02-10 |
4 |
B |
$0.84 |
$10,000 |
D/D |
11,976 |
931,976 |
2.39 |
% |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2016-04-08 |
4 |
A |
$1.14 |
$12,228 |
D/D |
10,726 |
196,446 |
0 |
- |
|
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2014-11-10 |
4 |
A |
$1.32 |
$12,500 |
D/D |
9,470 |
163,720 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2021-02-05 |
4 |
S |
$3.80 |
$15,200 |
D/D |
(4,000) |
746,000 |
0 |
% |
|
STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
|
2015-02-18 |
4 |
S |
$13.99 |
$22,944 |
D/D |
(1,640) |
130,133 |
0 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2021-02-18 |
4 |
S |
$4.20 |
$25,200 |
D/D |
(6,000) |
738,000 |
0 |
% |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2021-02-19 |
4 |
S |
$4.31 |
$34,480 |
D/D |
(8,000) |
730,000 |
0 |
% |
|
68 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|